An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell Lymphoma
Clinical trial NCT01724294 · TERMINATED
Trial details
- NCT number
- NCT01724294
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2012-12-01
- Primary completion
- 2016-04-01
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.